Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q). 1999

W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
Department of Pediatrics, University of Mannheim, Germany. w.scheurlen@kikli.ma.uni-heidelberg.de

Isochromosomes are monocentric or dicentric chromosomes with homologous arms that are attached in a reverse configuration as mirror images. With an incidence of 3-4%, the i(17q) represents the most frequent isochromosome in human cancer. It is found in a variety of tumors, particularly in blast crisis of chronic myeloid leukemia (CML-BC), acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and medulloblastoma (MB), and indicates a poor prognosis. To determine the breakpoints on the molecular genetic level, we analyzed 18 neoplasms (six CML, four AML, one NHL, and seven MB) with an i(17q) and two MB with a pure del(17p) applying fluorescence in situ hybridization (FISH) with yeast artificial chromosome (YAC) clones, P1-artificial chromosome (PAC) clones, and cosmids from a well-characterized contig covering more than 6 Mb of genomic DNA. We identified four different breakpoint cluster regions. One is located close to or within the centromere of chromosome 17 and a second in the Charcot-Marie-Tooth (CMT1A) region at 17(p11.2). A third breakpoint was found telomeric to the CMT1A region. The fourth, most common breakpoint was detected in MB, AML, and in CML-BC specimens and was bordered by two adjacent cosmid clones (clones D14149 and M0140) within the Smith-Magenis syndrome (SMS) region. These results indicate that the low copy number repeat gene clusters which are present in the CMT and SMS regions may be one of the factors for the increased instability that may trigger the formation of an i(17q).

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002503 Centromere The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Centromeres
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D005260 Female Females

Related Publications

W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
January 2001, Molekuliarnaia biologiia,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
October 1990, Oncogene,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
November 1990, Genes, chromosomes & cancer,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
February 1993, Human genetics,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
April 1981, Cancer genetics and cytogenetics,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
January 1974, Humangenetik,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
September 1992, Cancer genetics and cytogenetics,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
July 1987, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
May 1995, Genomics,
W G Scheurlen, and G C Schwabe, and P Seranski, and S Joos, and J Harbott, and S Metzke, and H Döhner, and A Poustka, and K Wilgenbus, and O A Haas
April 1989, Genomics,
Copied contents to your clipboard!